Annals of Epidemiology
Volume 9, Issue 5 , Pages 307-313 , July 1999

Distribution and Correlates of Elevated Total Homocyst(e)ine: The Stroke Prevention In Young Women Study

  • Wayne H Giles, MD, MS

      Affiliations

    • Cardiovascular Health Branch, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA USA
    • Corresponding Author InformationAddress reprint requests to: Wayne H. Giles, MD, MS, Cardiovascular Health Branch, CDC, 4770 Buford Hwy MS K-47, Atlanta, GA
    • ,
  • Steven J Kittner, MD, MPH

      Affiliations

    • Department of Neurology, University of Maryland School of Medicine, Baltimore, MD USA
    • Geriatrics Research, Education and Clinical Center, University of Maryland School of Medicine, Baltimore, MD USA
    • Department Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD USA
    • ,
  • Janet B Croft, PhD

      Affiliations

    • Cardiovascular Health Branch, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA USA
    • ,
  • Marcella A Wozniak, MD, PhD

      Affiliations

    • Department of Neurology, University of Maryland School of Medicine, Baltimore, MD USA
    • ,
  • Robert J Wityk, MD

      Affiliations

    • Department of Neurology, Johns Hopkins University, Baltimore, MD USA
    • ,
  • Barney J Stern, MD

      Affiliations

    • Department of Neurology, Emory University, Atlanta, GA USA
    • ,
  • Michael A Sloan, MD

      Affiliations

    • Department of Neurology, University of Maryland School of Medicine, Baltimore, MD USA
    • Department Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD USA
    • ,
  • Thomas R Price, MD

      Affiliations

    • Department of Neurology, University of Maryland School of Medicine, Baltimore, MD USA
    • Department Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD USA
    • ,
  • Robert J McCarter, ScD

      Affiliations

    • Department Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD USA
    • ,
  • Richard F Macko, MD

      Affiliations

    • Department of Neurology, University of Maryland School of Medicine, Baltimore, MD USA
    • Geriatrics Research, Education and Clinical Center, University of Maryland School of Medicine, Baltimore, MD USA
    • ,
  • Constance J Johnson, MD

      Affiliations

    • Department of Neurology, Johns Hopkins University, Baltimore, MD USA
    • ,
  • Barbara R Feeser, MPH

      Affiliations

    • Department of Neurology, University of Maryland School of Medicine, Baltimore, MD USA
    • ,
  • Christopher J Earley, MD, PhD

      Affiliations

    • Department of Neurology, Johns Hopkins University, Baltimore, MD USA
    • ,
  • David W Buchholz, MD

      Affiliations

    • Department of Neurology, Johns Hopkins University, Baltimore, MD USA
    • ,
  • Paul D Stolley, MD, MPH

      Affiliations

    • Department Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD USA

Received 22 June 1998 ,Revised 4 February 1999 ,Accepted 5 February 1999.

References 

  1. Israelsson B, Brattstrom LE, Hultberg BC. Homocysteine and myocardial infarction. Atherosclerosis. 1988;72:227–233
  2. Genest JJ, McNamara JR, Salem DN, Wilson PWF, Schaefer EJ, Malinow MR. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol. 1990;16:114–119
  3. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullman D, et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877–881
  4. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RC, Alvarez Jo , et al.  Plasma homocyst(e)ine, folate, and vitamin B-12 concentration and risk for early-onset coronary artery disease. Am J Clin Nutr. 1994;59:940–948
  5. Wu LL, Wu J, Hunt SC, James BC, Vincent GM, Williams RR, et al.  Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem. 1994;40:552–561
  6. von Eckardstein A, Malinow MR, Upson B, Heinrich J, Schulte H, Schonfeld R, et al.  Effect of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)ine as a cardiovascular disease risk factor in men. Aterioscler Thromb. 1994;14:460–464
  7. Brattstrom L, Israelsson B, Norving B, Bergqvist D, Thorne J, Hultberg B, et al.  Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive disease. Atherosclerosis. 1990;81:51–60
  8. Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, deGarmo P. Elevated plasma homocyt(e)ine concentrations as a possible independent risk factor for stroke. Stroke. 1990;21:572–576
  9. Verhoef P, Hennekens CH, Malinow RM, Kok FJ, Willett WC, Stampfer MJ. A prospective study of plasma homocysteine and risk for ischemic stroke. Stroke. 1994;25:1924–1930
  10. Malinow MR, Kang SS, Taylor LM, Wong PW, Coull B, Inahara T, et al.  Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation. 1989;79:1180–1188
  11. Taylor LM, DeFrang RD, Harris EJ, Porter JM. The association of elevated plasma homocysteine with progressive symptomatic peripheral arterial disease. J Vasc Surg. 1991;13:128–136
  12. Boushey CJ, Beresford SAA, Omen GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease (Probable benefits of increasing folate intakes). JAMA. 1995;274:1049–1057
  13. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693–2698
  14. Kang SS, Wong PWK, Norusis M. Homocysteinemia due to folate deficiency. Metabolism. 1987;36:458–462
  15. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al.  Total plasma homocysteine and cardiovascular risk profile (The Hordaland Homocysteine Study). JAMA. 1995;274:1526–1533
  16. Nygard O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocyst(e)ine distribution (The Hordaland Homocyst(e)ine Study). Am J Clin Nutr. 1998;67:263–270
  17. Kittner SJ, Malinow MR, Seipp MJ, Upson B, Hebel JR. Stability of blood homocyst(e)ine under epidemiological field conditions. J Clin Lab Anal. 1995;9:75–76
  18. Smolin LA, Scheider JA. Measurement of total plasma cysteamine using high-performance liquid chromatography with electrochemical detection. Anal Biochem. 1988;168:374–379
  19. Malinow MR, Sexton G, Averbuch M, Grossman M, Wilson D, Upson B. Hyperhomocyst(e)imemia in daily practice (Levels in coronary artery disease). Coronary Artery Dis. 1990;1:215–220
  20. Selhub J, Jacques PF, Bostom AG, D’Agostino RB, Wilson PW, Belanger AJ. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286–291
  21. Federation of American Societies for Experimental Biology, Life Sciences Research Office. Prepared for the Interagency Board for Nutrition Monitoring and Related Research 1995. Third Report for Nutrition Monitoring in the United States, v. 1. Washington, DC. US Government Printing Office; 1995.
  22. Motulsky AG. Nutritional ecogenetics (Homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid). Am J Hum Genet. 1996;58:17–20
  23. Stevenson RE, Schwartz CE, Du YZ, Adams MJ. Differences in methylenetetrahydrofolate reductase genotype frequencies between whites and blacks. Am J Hum Genet. 1997;60:229–230
  24. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al.  A candidate genetic risk factor for vascular disease (A common mutation in methylenetetrahydrofolate reductase). Nat Genet. 1995;10:111–113
  25. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentration. Circulation. 1996;93:7–9
  26. Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyette P, Rosenblatt DS, et al.  Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol. 1997;17:569–573
  27. Giles WH, Kittner SJ, Ou CY, Croft JB, Brown V, Bucholtz DW, et al.  Thermolabile methylenetetrahydrofolate reductase polymorphism (C677T) and total homocyst(e)ine concentration among African American and white women. Ethnicity Dis. 1998;8:149–157
  28. Arnesen E, Refsum H, Bønaa KH, Ueland PM, Førde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol. 1995;24:704–709
  29. Kang SS, Wong PWK, Cook HY, Norusis M, Messer JV. Protein-bound homocyst(e)ine (A possible risk factor for coronary artery stenosis). N Engl J Med. 1995;332:268–291
  30. Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T, Kita T. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis. 1989;79:139–146
  31. Hultberg B, Berglund M, Andersson A, Frank A. Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res. 1993;17:687–689
  32. Mansoor MA, Bergmark C, Svardal AM, Lonning PE, Ueland PM. Redux status and protein binding in plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol. 1995;15:232–240
  33. Pryor WA, Stone K. Oxidants in cigarette smoke (radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite). Ann N Y Acad Sci. 1993;686:12–28
  34. Piyathilake CJ, Macaluso M, Hine RJ, Richards EW, Krumdieck CL. Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr. 1994;60:559–566
  35. Chen AT, Reidy JA, Annest JL, Welty TK, Zhou HG. Increased chromosome fragility as a consequence of blood folate levels, smoking status, and coffee consumption. Environ Mol Mutagen. 1989;13:19–24
  36. Dastur DK, Quadros EV, Wadia NH, Desai MM, Bharucha EP. Effect of vegetarianism and smoking on vitamin B-12, thiocyanate, and folate levels in the blood of normal subjects. BMJ. 1972;3:230–263
  37. Linnel JC, Smith ADM, Smith CL, Wilson J, Matthews DM. Effects of smoking on metabolism and excretion of vitamin B-12. BMJ. 1968;2:215–216
  38. CDC . Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR. 1992;41(14):1–5
  39. CDC . Knowledge and use of folic acid by women of childbearing age—United States, 1995. MMWR. 1995;44:716–718

PII: S1047-2797(99)00006-X

Annals of Epidemiology
Volume 9, Issue 5 , Pages 307-313 , July 1999

Article Tools

* Image Usage & Resolution